Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.38 |
| ▸ | CFTR | P13569 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | GCGR | P47871 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7915227 | 0.85 | KDM4E (0.58) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL10695260 | 0.85 | KDM4E (0.58) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797469 | 0.83 | KDM4E (0.67) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL5678561 | 0.79 | KDM4E (0.53) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797401 | 0.79 | LDHA (0.37) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL10530656 | 0.78 | KDM4E (0.46) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL3730672 | 0.78 | KDM4E (0.56) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL796895 | 0.77 | KDM4E (0.55) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797164 | 0.77 | KDM4E (0.50) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797440 | 0.77 | GCGR (0.34) | KDM4EALDH1A1HPGDGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1262469-B1 | POLYACENE DERIVATIVES AND PRODUCTION THEREOF | JAPAN SCIENCE & TECH AGENCY (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-7901594-B2 | Electroconductivity | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20050240061-A1 | Functional thin film | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 2005-10-27 | — | — | US | disclosed |
| EP-1493796-A1 | FUNCTIONAL THIN FILM | Japan Science and Technology Agency (JP) | 2005-01-05 | — | — | EP | disclosed |
| US-20030116755-A1 | Polyacene derivatives and production thereof | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1262469-A1 | POLYACENE DERIVATIVES AND PRODUCTION THEREOF | Japan Science and Technology Corporation (JP) | 2002-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240061-A1 | Functional thin film | H1-10, H1-0, H1-2 | KDM4E 2385/4885ALDH1A1 1285/4885HPGD 4240/4885 |
| US-20030116755-A1 | Polyacene derivatives and production thereof | CBR1, HVCN1, H1-0 | KDM4E 1200/4885ALDH1A1 591/4885HPGD 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.